DAWN FLOYD: Open Payments
NPI 1346539533 · TIFTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,736 in 57 payments from 11 companies in 2025. Trend: 2023 $799 · 2024 $1,007 · 2025 $1,736
Food & beverage: $1,402Travel & lodging: $335
| Company | Payments | Amount |
|---|---|---|
| Penumbra, Inc. | 7 | $867 |
| Novo Nordisk Inc | 16 | $279 |
| Lilly USA, LLC | 8 | $127 |
| ABBVIE INC. | 5 | $104 |
| Ardelyx, Inc. | 4 | $79 |
| PFIZER INC. | 4 | $69 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| Astellas Pharma US Inc | 3 | $65 |
| Amgen Inc. | 4 | $56 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Indigo System, Ozempic, Penumbra System, MOUNJARO, VRAYLAR, IBSRELA, Wegovy, Veozah.
Industry payments across GA — which companies pay providers there.
